Sildenafil 4.0—Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era

Sildenafil is a potent selective, reversible inhibitor of phosphodiesterase type 5 (PDE5) approved for the treatment of erectile dysfunction and pulmonary arterial hypertension. Whilst twenty years have passed since its original approval by the US Food and Drug Administration (USFDA), sildenafil ent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceuticals (Basel)
Autors principals: Ouranidis, Andreas, Tsiaxerli, Anastasia, Vardaka, Elisavet, Markopoulou, Catherine K., Zacharis, Constantinos K., Nicolaou, Ioannis, Hatzichristou, Dimitris, Haidich, Anna-Bettina, Kostomitsopoulos, Nikolaos, Kachrimanis, Kyriakos
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071249/
https://ncbi.nlm.nih.gov/pubmed/33920975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040365
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars